Tag: SGLT2 inhibitors

SGLT2 Inhibitors for Type 2 Diabetes: What You Need to Know About Benefits and Risks

SGLT2 Inhibitors for Type 2 Diabetes: What You Need to Know About Benefits and Risks

SGLT2 inhibitors like Jardiance and Farxiga lower blood sugar, help with weight loss, and protect the heart and kidneys - but they come with risks like yeast infections and rare ketoacidosis. Here’s what patients and doctors need to know.

view more
SGLT2 Inhibitors in Type 2 Diabetes: How They Protect Heart and Kidneys

SGLT2 Inhibitors in Type 2 Diabetes: How They Protect Heart and Kidneys

SGLT2 inhibitors like empagliflozin and dapagliflozin now offer proven heart and kidney protection for people with type 2 diabetes, shifting treatment from glucose control to organ preservation. Learn how they work, who benefits most, and what risks to watch for.

view more

Menu

© 2026. All rights reserved.